Literature DB >> 6291687

Dopamine acts at the same receptors as noradrenaline in the rat isolated vas deferens.

J A Leedham, J N Pennefather.   

Abstract

1 The proposal that dopamine activates a different population of receptors from those activated by noradrenaline and phenylephrine to cause contraction of the rat vas deferens has been investigated using a preparation of the epididymal half of this tissue. 2 In preparations preincubated in cocaine, oestradiol and propranolol, to block sites of amine loss and beta-adrenoceptors, noradrenaline was the most, and dopamine the least, potent of the three agonists. Phentolamine competitively inhibited each of the agonists to a similar extent. Prazosin also inhibited the actions of the three agonists to a similar extent. These results indicate that the three agonists activate a single population of alpha 1-adrenoceptors to cause contraction in this preparation. 3 In experiments using the prostatic half of the rat vas deferens, in the presence of cocaine, oestradiol, propranolol and prazosin, noradrenaline was approximately 40 times more potent than dopamine in causing inhibition of twitches induced by electrical field stimulation. Yohimbine competitively antagonized the effects of the two agonists to a similar extent indicating that both act at the same population of alpha 2-adrenoceptors. 4 Taken together, these findings do not lend support to proposals that there are populations of specific dopamine receptors located pre- and postjunctionally in the rat vas deferens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291687      PMCID: PMC2044591          DOI: 10.1111/j.1476-5381.1982.tb09298.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors.

Authors:  J C Doxey; C F Smith; J M Walker
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

2.  Prejunctional inhibitory alpha-adrenoceptors and dopaminoceptors of the rat vas deferens and the guinea-pig ileum in vitro.

Authors:  F M Tayo
Journal:  Eur J Pharmacol       Date:  1979-09-15       Impact factor: 4.432

3.  A comparative study on the pre- and post-synaptic alpha blocking activity of a series of benzodioxanes.

Authors:  H Kapur; D R Mottram
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

4.  Regional variation in the distribution of alpha-adrenoreceptors in the vas deferens of the rat.

Authors:  L Vardolov; J N Pennefather
Journal:  Arch Int Pharmacodyn Ther       Date:  1976-06

5.  Further evidence for dopaminoceptors in the vas deferens [proceedings].

Authors:  F M Tayo; G Osuide
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

6.  Analysis of the effects of apomorphine and bulbocapnine in relation to the proposed dopamine receptor.

Authors:  P N Patil; A M Burkman; D Yamauchi; S Hetey
Journal:  J Pharm Pharmacol       Date:  1973-03       Impact factor: 3.765

7.  Effect of duration and frequency of stimulation on the presynaptic inhibition by alpha-adrenoceptor stimulation of the adrenergic transmission.

Authors:  E S Vizi; G T Somogyi; P Hadházy; J Knoll
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

8.  The effects of alpha-adrenoceptor agonists and antagonists on responses of transmurally stimulated prostatic and epididymal portions of the isolated vas deferens of the rat.

Authors:  C M Brown; J C McGrath; R J Summers
Journal:  Br J Pharmacol       Date:  1979-08       Impact factor: 8.739

9.  Dopamine receptors and dopaminergic nerves in the vas deferens of the rat.

Authors:  A Simon; E F Van Maanen
Journal:  Arch Int Pharmacodyn Ther       Date:  1976-07

10.  Occurrence of excitatory dopaminoceptors in the rat and guinea-pig vas deferens.

Authors:  F M Tayo
Journal:  Clin Exp Pharmacol Physiol       Date:  1979 May-Jun       Impact factor: 2.557

View more
  1 in total

1.  Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists.

Authors:  R J Gould; K M Murphy; I J Reynolds; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.